Patent RDF
- Device and method for delivering therapeutic substances to the maxillary sinus of a patient
- Lipid growth factor formulations
- Method for protecting and treating at least one muscarinic receptor from dysfunction resulting from free radical damage
- Method of treating Parkinson's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavity
- Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system
- Treatment of central nervous system disorders by intranasal administration of immunoglobulin g
- Treatment of hypoglycemia unawareness with intranasal insulin